BSEGeneral2 Nov 2026 · 2 Nov 2026, 04:50 pm
Brookfield India Real Estate Trust REIT has informed the Exchange regarding Disclosure of material issue
Brookfield India Real Estate Trust REIT · 543261
✦ AI SummaryFundraise
Brookfield India Real Estate Trust REIT has informed the Exchange regarding Disclosure of material issue related to the utilization of proceeds from the issue of Commercial Papers.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brookfield India Real Estate Trust REIT - 543261 - Reg 23(5)(i): Disclosure of material issue
Attachments (1)
📄pdf
Download →
f61fea5c-2ad6-42f2-9082-6aaef4d5ff17.pdf
View document text
November 02, 2026
BSE Limited National Stock Exchange of India
The Corporate Relations Department, Limited
25th Floor, P J Towers, Dalal Street The Corporate Relations Department
Fort, Mumbai – 400 001 Exchange Plaza, 5th Floor,
SCRIP CODE: 543261 Plot no. C/1, G Block
SCRIP ID: BIRET Bandra-Kurla Complex, Bandra(E),
NCD SCRIP CODE: 977393 Mumbai – 400 051
NCD ISIN: INE0FDU07018 SYMBOL: BIRET
SCRIP CODE OF CP – 732621
SCRIP ID OF CP – BIRET21926
Sub: Statement of utilization for issue proceeds of Commercial Papers.
Dear Sir/Ma’am,
Please note that Brookfield India Real Estate Trust (“Brookfield India REIT”) has raised funds by way of issue of
Commercial Papers for an amount of Rs. 2600 million, on September 21, 2026. Further, in terms of the provisions
of regulation 52(7) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“SEBI Listing Regulations”) and read with Chapter XVII of SEBI Master Circular having ref no.
SEBI/HO/DDHS/DDHSPoD/P/CIR/2025/ 0000000137 dated October 15, 2025, the proceeds of the
Commercial Papers have been utilized, in line with the objects stated in the Key Information Document dated
September 17, 2026 of the above said Commercial Paper(s), during the quarter ended September 30, 2026,
without any deviations or variations.
In this regard, the statement of deviation/variation in use of proceeds of Commercial Papers till quarter ended
September 30, 2026, is enclosed as Annexure I.
Thanking You.
Yours Faithfully,
For Brookprop Management Services Private Limited
(as manager of Brookfield India Real Estate Trust)
Saurabh Jain
Company Secretary & Compliance Officer
Axis Trustee Services Limited
Axis House, P B Marg, Worli,
Mumbai, Maharashtra, India, 400025
IDBI Trusteeship Service Limited (Debenture Trustee for the NCDs)
Universal Insurance Building, Ground Floor, Sir P.M. Road,
Fort, Mumbai – 400001
BROOKFIELD INDIA REAL ESTATE TRUST acting through its manager - BROOKPROP MANAGEMENT SERVICES PRIVATE LIMITED
Registered Office of Manager: Godrej BKC, Office No.2, 4th Floor, Plot C-68, 3rd Avenue, G-Block, Bandra Kurla Complex, Mumbai – 400051
Principal Place of Business 1st Floor, Asset No. 8, Unit No. 101, Worldmark-2, Hospitality District Aerocity, IGI Airport, New Delhi 110037
T: +91 11 4929 5555; 022-45832450 E: reit.compliance@brookfield.com; reit.manager@brookfield.com SEBI registration No. – IN/REIT/20-21/0004
Website of Brookfield India Real Estate Trust: https://www.brookfieldindiareit.in/ CIN: U74999MH2018FTC306865
ANNEXURE I
A. STATEMENT OF UTILISATION OF ISSUE PROCEEDS
Name of the Issuer ISIN Mode of Type of Date of Amount Funds Any If 8 is Rema
Fund Instrument raising raised (in utilized till deviation Yes, rks, if
Raising funds million) September (Yes/No) then any
(Public 30, 2026 (in specify
Issues/ million) the
Private purpose
Placemen of for
t) which
funds
were
utilized
1 2 3 4 5 6 7 8 9 10
Brookfield India INE0FDU14055 Private Commercial September Upto Rs. Rs. 1,625 No NA -
Real Estate Trust Placement Paper 21, 2026 2,529.64 million
Million*
*On September 21, 2026, Brookfield India REIT issued 5,200 commercial papers with a face value of Rs. 5,00,000/- each at 7.20% per annum. The
discounted amount raised by the Brookfield India REIT through commercial paper was Rs. 2,529.64 million and value to be payable on maturity is Rs. 2,600
million.
B. STATEMENT OF DEVIATION/VARIATION IN USE OF ISSUE PROCEEDS
Name of listed entity Brookfield India Real Estate Trust (Brookfield India
REIT)
Mode of fund Raising Issue of Commercial Papers
Type of instrument Commercial Paper
Date of raising Funds September 21, 2026 (Date of Issue)
Amount raised (in Rs.) INR 2,600,000,000*
Report filed for Quarter ended September 30, 2026
Is there a deviation/ variation in use of funds raised? No
Whether any approval is required to vary the No
objects of the issue stated in the prospectus/ offer
document?
If yes, details of the approval so required? Not Applicable
Date of approval Not Applicable
Explanation for the Deviation / Variation Not Applicable
Comments of the Audit Committee after review None
Comments of the auditors, if any None
Set forth below are objects for which funds have been raised in the issue of Commercial Papers by Brookfield India
REIT and details of deviation/variation, if any, in the following table:
BROOKFIELD INDIA REAL ESTATE TRUST acting through its manager - BROOKPROP MANAGEMENT SERVICES PRIVATE LIMITED
Registered Office of Manager: Godrej BKC, Office No.2, 4th Floor, Plot C-68, 3rd Avenue, G-Block, Bandra Kurla Complex, Mumbai – 400051
Principal Place of Business 1st Floor, Asset No. 8, Unit No. 101, Worldmark-2, Hospitality District Aerocity, IGI Airport, New Delhi 110037
T: +91 11 4929 5555; 022-45832450 E: reit.compliance@brookfield.com; reit.manager@brookfield.com SEBI registration No. – IN/REIT/20-21/0004
Website of Brookfield India Real Estate Trust: https://www.brookfieldindiareit.in/ CIN: U74999MH2018FTC306865
Original Object Modified Original Modified Funds Utilized Amount of Remarks if
Object, if Allocation Allocation till September Deviation/Variation any
any (Rs./Mn) , if any 30, 2026 for Quarter
(Rs./Mn) according to
applicable object
Proceeds of the Issue will be used for NA 2,529.64 NA 1,625.00 - -
partial and/ or full prepayment and/
or scheduled repayment of certain
debt facilities and/or loan and/or
borrowings availed by the Brookfield
India REIT and/or Holdco, and/or
Asset SPVs, and/or Operational
Service Provider Company, (by
providing shareholder loans to such
Holdco, Asset SPV, Operational
Service Provider Company, present
or future by the Brookfield India
REIT), general corporate purposes
including, without limitation to
transaction expenses, capital
expenditure, working capital
requirement & operational and other
expenses of Issuer and its Holdco
and/or Asset SPVs and/or
Operational Service Provider
Company (present or future), (by
providing shareholder loans to such
Holdco, Asset SPV, Operational
Service Provider Company, present
or future by the Brookfield India REIT)
Total 2529.64 1,625.00
*On September 21, 2026, Brookfield India REIT issued 5,200 commercial papers with a face value of Rs. 5,00,000/- each at 7.20% per annum.
The discounted amount raised by the Brookfield India REIT through commercial paper was INR 2,52,96,41,400 and value to be payable on
maturity is INR 2,600,000,000.
Deviation could mean:
a) Deviation in the objects or purposes for which the funds have been raised.
b) Deviation in the amount of funds actually utilized as against what was originally disclosed
Name of Signatory: Saurabh Jain
Designation: Company Secretary & Compliance Officer
Date: November 02, 2026
BROOKFIELD INDIA REAL ESTATE TRUST acting through its manager - BROOKPROP MANAGEMENT SERVICES PRIVATE LIMITED
Registered Office of Manager: Godrej BKC, Office No.2, 4th Floor, Plot C-68, 3rd Avenue, G-Block, Bandra Kurla Complex, Mumbai – 400051
Principal Place of Business 1st Floor, Asset No. 8, Unit No. 101, Worldmark-2, Hospitality District Aerocity, IGI Airport, New Delhi 110037
T: +91 11 4929 5555; 022-45832450 E: reit.compliance@brookfield.com; reit.manager@brookfield.com SEBI registration No. – IN/REIT/20-21/0004
Website of Brookfield India Real Estate Trust: https://www.brookfieldindiareit.in/ CIN: U74999MH2018FTC306865